Industry Research Reports
Global Organ On Chip Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-08-15
Pages: 160 Pages
Report ld: 5524070
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Organ On Chip Market Size(US$)
CAGR 2026-2032
30.2%
Market Size,2032
USD 1,368
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 281 million
Market Forecast in 2032(Value)
US$ 1,368 million
CAGR
30.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Organ On Chip market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 1368 million by 2032, at a CAGR of 30.2% from 2026 to 2032.
A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.The price of Organ-on-Chip products varies significantly depending on chip architecture, number of microfluidic channels, integration of perfusion or sensing functions, and automation level. In 2025–2026, basic microfluidic organ-on-chip devices are generally priced at around US$20–100 per chip, while multi-well or high-throughput chip plates are typically about US$80–500 per plate. Supporting pumps, controllers, and culture modules usually cost approximately US$3,000–20,000 per system, while fully integrated and automated organ-on-chip platforms may exceed US$20,000–100,000 per system.
The upstream value chain mainly includes chip substrate materials such as PDMS, COP/COC, and glass, together with porous membranes, ECM/hydrogels, cells, culture media, sensors, and microfluidic components. Midstream companies such as Emulate, MIMETAS, TissUse, CN Bio, and AIM Biotech are responsible for microfluidic chip design, manufacturing, and integration of culture and perfusion systems. Downstream users mainly include pharmaceutical and biotechnology companies, CROs, academic and research institutions, and regulatory science organizations. Organ-on-chip platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.
Market Drivers
Regulatory Support for Reducing Animal Testing
Global drug development regulations are increasingly encouraging the adoption of non-animal testing methods. Organ-on-chip systems can use human-derived cells to reproduce organ-specific microenvironments and physiological functions, offering stronger human relevance for drug safety, toxicology, and efficacy assessment. Continued support from regulatory and research organizations such as the FDA, NIH, and European institutions is accelerating the adoption and commercialization of microphysiological systems and organ-on-chip technologies.
Growing Demand to Improve Pharmaceutical R&D Efficiency
Traditional two-dimensional cell cultures and animal models have limitations in predicting human drug responses. Organ-on-chip platforms combine three-dimensional cell culture, microfluidics, dynamic perfusion, and multicellular co-culture to better reproduce human tissue environments. As drug development costs continue to rise, pharmaceutical companies are increasingly using organ-on-chip systems for candidate screening, ADME/DMPK studies, toxicity testing, and disease modeling.
Increasing Demand for Precision Medicine and Human-Relevant Disease Models
Organ-on-chip technologies can be integrated with patient-derived cells, induced pluripotent stem cells, organoids, and gene-editing technologies to create human-relevant models with specific genetic and disease characteristics. Growing demand for precision treatment in oncology, neurological disorders, rare diseases, and metabolic diseases is expanding the application of organ-on-chip systems in personalized drug screening, disease mechanism research, and patient stratification.
Market Restraints
Relatively High Equipment and Experimental Costs
Organ-on-chip experiments often require microfluidic chips, specialized culture media, extracellular matrices, hydrogels, pumping systems, sensors, and imaging equipment. Overall experimental costs are generally higher than conventional two-dimensional cell culture and standard microplate assays. Integrated and automated organ-on-chip platforms also require relatively high initial capital investment, which can limit adoption among small laboratories and research institutions with restricted budgets.
Limited Standardization Across Platforms
Organ-on-chip manufacturers use different chip materials, channel geometries, membranes, cell sources, culture conditions, flow rates, and analytical methods. The industry has not yet established fully standardized technical specifications and evaluation systems. Differences among platforms may reduce inter-laboratory reproducibility and data comparability, creating barriers to broader adoption in standardized pharmaceutical development and regulatory assessment.
Constraints in High-Quality Cell Sources and Long-Term Culture
The performance of organ-on-chip systems strongly depends on the quality of primary cells, stem-cell-derived cells, and other human-derived biological materials. Some organ-specific cell types remain difficult to obtain and may exhibit batch-to-batch variability, phenotype instability, or limited long-term viability. Variability in cellular materials can directly affect experimental consistency and complicate large-scale deployment and standardized validation.Market Opportunities
Expanding Applications in Drug Safety and Toxicology Assessment
Organ-on-chip platforms have significant potential in drug-induced liver injury, cardiotoxicity, nephrotoxicity, pulmonary toxicity, and blood-brain barrier studies. As regulatory authorities gradually increase acceptance of human-relevant alternative models, organ-on-chip systems are expected to move beyond academic research and become increasingly integrated into preclinical safety assessment workflows, creating strong opportunities for liver-on-chip, heart-on-chip, kidney-on-chip, and related platforms.
Development of High-Throughput and Automated Platforms
The industry is moving from individual microfluidic devices toward multi-well-compatible, high-throughput, and automated systems. These platforms are increasingly integrated with automated liquid handling, high-content imaging, real-time biosensors, and AI-based data analysis. High-throughput systems can reduce per-test costs, improve reproducibility, and facilitate integration into existing pharmaceutical screening workflows, supporting growth in both consumable chips and supporting instruments.
Strong Potential for Multi-Organ and Body-on-Chip Systems
Multi-organ platforms can connect liver, intestine, kidney, heart, and other tissue models to investigate drug absorption, distribution, metabolism, excretion, and organ-to-organ interactions. As microfluidic control, long-term culture, and multi-organ coupling technologies continue to improve, these systems are expected to gain wider use in systemic toxicology, PK/PD analysis, and complex disease modeling, creating new high-value market segments.
Market Challenges
Balancing Physiological Relevance with Throughput
Organ-on-chip systems rely on multicellular co-culture, three-dimensional extracellular matrices, mechanical stimulation, dynamic fluid flow, and sensing technologies to improve physiological relevance. However, greater biological complexity generally increases manufacturing costs, operational difficulty, and experimental failure risks. Achieving an effective balance among model complexity, reproducibility, throughput, cost, and ease of use remains a major technical challenge for large-scale commercialization.
Regulatory Acceptance Requires Extensive Validation
Although regulatory authorities are showing increasing interest in organ-on-chip and microphysiological systems, replacing conventional animal testing or using these platforms for formal regulatory decision-making still requires extensive inter-laboratory validation, reference-compound testing, and comparison with clinical data. Different organ models may progress through validation and regulatory acceptance at different speeds, potentially slowing commercial adoption.
Competition Among Multiple Technology Platforms
The market includes membrane-based, membrane-free, ECM-based microfluidic, multi-well plate, pump-driven, and gravity-driven organ-on-chip architectures. Each platform has different advantages in physiological relevance, throughput, operational complexity, and cost. Uncertainty over which technologies will ultimately become widely accepted by pharmaceutical companies and regulatory authorities increases R&D risks for manufacturers and platform-selection risks for customers.
MARKET SEGMENTATION
By Company
- Emulate
- MIMETAS
- TissUse
- CN Bio Innovations
- AIM Biotech
- AlveoliX
- Beonchip
- React4life
- InSphero
- NETRI
- SynVivo
- BiomimX
- Dynamic42
- Kirkstall
- Cherry Biotech
- Micronit
- Cellbox Labs
- REVIVO BioSystems
- MesoBioTech
- Beijing Daxiang Biotech
- AVATARGET
- Suzhou Jiyan Biopharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Segment by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
Segment by Category
- Single-organ-on-Chip
- Multi-organ-on-Chip
Segment by Division
- Membrane-based Organ-on-Chip
- Membrane-free Organ-on-Chip
REPORT SCOPE
This report delivers a comprehensive overview of the global Organ On Chip market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Organ On Chip. The Organ On Chip market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Organ On Chip market comprehensively. Regional market sizes by Type, by End User, by System Integration, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Organ On Chip manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, by System Integration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Organ On Chip companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by End User, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ On Chip Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market by System Integration
1.3.1 Global Organ On Chip Market Size Growth Rate by System Integration: 2021 vs 2025 vs 2032
1.3.2 Single-organ-on-Chip
1.3.3 Multi-organ-on-Chip
1.4 Market by Chip Structure
1.4.1 Global Organ On Chip Market Size Growth Rate by Chip Structure: 2021 vs 2025 vs 2032
1.4.2 Membrane-based Organ-on-Chip
1.4.3 Membrane-free Organ-on-Chip
1.5 Market by End User
1.5.1 Global Organ On Chip Market Growth by End User: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Academic & Research Institutes
1.5.4 Cosmetics Industry
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Organ On Chip Market Perspective (2021–2032)
2.2 Global Organ On Chip Growth Trends by Region
2.2.1 Global Organ On Chip Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Organ On Chip Historic Market Size by Region (2021–2026)
2.2.3 Organ On Chip Forecasted Market Size by Region (2027–2032)
2.3 Organ On Chip Market Dynamics
2.3.1 Organ On Chip Industry Trends
2.3.2 Organ On Chip Market Drivers
2.3.3 Organ On Chip Market Challenges
2.3.4 Organ On Chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ On Chip Players by Revenue
3.1.1 Global Top Organ On Chip Players by Revenue (2021–2026)
3.1.2 Global Organ On Chip Revenue Market Share by Players (2021–2026)
3.2 Global Top Organ On Chip Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Organ On Chip Revenue
3.4 Global Organ On Chip Market Concentration Ratio
3.4.1 Global Organ On Chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ On Chip Revenue in 2025
3.5 Global Key Players of Organ On Chip Head Offices and Areas Served
3.6 Global Key Players of Organ On Chip, Products and Applications
3.7 Global Key Players of Organ On Chip, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Organ On Chip Breakdown Data by Type
4.1 Global Organ On Chip Historic Market Size by Type (2021–2026)
4.2 Global Organ On Chip Forecasted Market Size by Type (2027–2032)
5 Organ On Chip Breakdown Data by End User
5.1 Global Organ On Chip Historic Market Size by End User (2021–2026)
5.2 Global Organ On Chip Forecasted Market Size by End User (2027–2032)
6 North America
6.1 North America Organ On Chip Market Size (2021–2032)
6.2 North America Organ On Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Organ On Chip Market Size by Country (2021–2026)
6.4 North America Organ On Chip Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ On Chip Market Size (2021–2032)
7.2 Europe Organ On Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Organ On Chip Market Size by Country (2021–2026)
7.4 Europe Organ On Chip Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Organ On Chip Market Size (2021–2032)
8.2 Asia-Pacific Organ On Chip Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Organ On Chip Market Size by Region (2021–2026)
8.4 Asia-Pacific Organ On Chip Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Organ On Chip Market Size (2021–2032)
9.2 Latin America Organ On Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Organ On Chip Market Size by Country (2021–2026)
9.4 Latin America Organ On Chip Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ On Chip Market Size (2021–2032)
10.2 Middle East & Africa Organ On Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Organ On Chip Market Size by Country (2021–2026)
10.4 Middle East & Africa Organ On Chip Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ On Chip Introduction
11.1.4 Emulate Revenue in Organ On Chip Business (2021–2026)
11.1.5 Emulate Recent Development
11.2 MIMETAS
11.2.1 MIMETAS Company Details
11.2.2 MIMETAS Business Overview
11.2.3 MIMETAS Organ On Chip Introduction
11.2.4 MIMETAS Revenue in Organ On Chip Business (2021–2026)
11.2.5 MIMETAS Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Organ On Chip Introduction
11.3.4 TissUse Revenue in Organ On Chip Business (2021–2026)
11.3.5 TissUse Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Details
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Organ On Chip Introduction
11.4.4 CN Bio Innovations Revenue in Organ On Chip Business (2021–2026)
11.4.5 CN Bio Innovations Recent Development
11.5 AIM Biotech
11.5.1 AIM Biotech Company Details
11.5.2 AIM Biotech Business Overview
11.5.3 AIM Biotech Organ On Chip Introduction
11.5.4 AIM Biotech Revenue in Organ On Chip Business (2021–2026)
11.5.5 AIM Biotech Recent Development
11.6 AlveoliX
11.6.1 AlveoliX Company Details
11.6.2 AlveoliX Business Overview
11.6.3 AlveoliX Organ On Chip Introduction
11.6.4 AlveoliX Revenue in Organ On Chip Business (2021–2026)
11.6.5 AlveoliX Recent Development
11.7 Beonchip
11.7.1 Beonchip Company Details
11.7.2 Beonchip Business Overview
11.7.3 Beonchip Organ On Chip Introduction
11.7.4 Beonchip Revenue in Organ On Chip Business (2021–2026)
11.7.5 Beonchip Recent Development
11.8 React4life
11.8.1 React4life Company Details
11.8.2 React4life Business Overview
11.8.3 React4life Organ On Chip Introduction
11.8.4 React4life Revenue in Organ On Chip Business (2021–2026)
11.8.5 React4life Recent Development
11.9 InSphero
11.9.1 InSphero Company Details
11.9.2 InSphero Business Overview
11.9.3 InSphero Organ On Chip Introduction
11.9.4 InSphero Revenue in Organ On Chip Business (2021–2026)
11.9.5 InSphero Recent Development
11.10 NETRI
11.10.1 NETRI Company Details
11.10.2 NETRI Business Overview
11.10.3 NETRI Organ On Chip Introduction
11.10.4 NETRI Revenue in Organ On Chip Business (2021–2026)
11.10.5 NETRI Recent Development
11.11 SynVivo
11.11.1 SynVivo Company Details
11.11.2 SynVivo Business Overview
11.11.3 SynVivo Organ On Chip Introduction
11.11.4 SynVivo Revenue in Organ On Chip Business (2021–2026)
11.11.5 SynVivo Recent Development
11.12 BiomimX
11.12.1 BiomimX Company Details
11.12.2 BiomimX Business Overview
11.12.3 BiomimX Organ On Chip Introduction
11.12.4 BiomimX Revenue in Organ On Chip Business (2021–2026)
11.12.5 BiomimX Recent Development
11.13 Dynamic42
11.13.1 Dynamic42 Company Details
11.13.2 Dynamic42 Business Overview
11.13.3 Dynamic42 Organ On Chip Introduction
11.13.4 Dynamic42 Revenue in Organ On Chip Business (2021–2026)
11.13.5 Dynamic42 Recent Development
11.14 Kirkstall
11.14.1 Kirkstall Company Details
11.14.2 Kirkstall Business Overview
11.14.3 Kirkstall Organ On Chip Introduction
11.14.4 Kirkstall Revenue in Organ On Chip Business (2021–2026)
11.14.5 Kirkstall Recent Development
11.15 Cherry Biotech
11.15.1 Cherry Biotech Company Details
11.15.2 Cherry Biotech Business Overview
11.15.3 Cherry Biotech Organ On Chip Introduction
11.15.4 Cherry Biotech Revenue in Organ On Chip Business (2021–2026)
11.15.5 Cherry Biotech Recent Development
11.16 Micronit
11.16.1 Micronit Company Details
11.16.2 Micronit Business Overview
11.16.3 Micronit Organ On Chip Introduction
11.16.4 Micronit Revenue in Organ On Chip Business (2021–2026)
11.16.5 Micronit Recent Development
11.17 Cellbox Labs
11.17.1 Cellbox Labs Company Details
11.17.2 Cellbox Labs Business Overview
11.17.3 Cellbox Labs Organ On Chip Introduction
11.17.4 Cellbox Labs Revenue in Organ On Chip Business (2021–2026)
11.17.5 Cellbox Labs Recent Development
11.18 REVIVO BioSystems
11.18.1 REVIVO BioSystems Company Details
11.18.2 REVIVO BioSystems Business Overview
11.18.3 REVIVO BioSystems Organ On Chip Introduction
11.18.4 REVIVO BioSystems Revenue in Organ On Chip Business (2021–2026)
11.18.5 REVIVO BioSystems Recent Development
11.19 MesoBioTech
11.19.1 MesoBioTech Company Details
11.19.2 MesoBioTech Business Overview
11.19.3 MesoBioTech Organ On Chip Introduction
11.19.4 MesoBioTech Revenue in Organ On Chip Business (2021–2026)
11.19.5 MesoBioTech Recent Development
11.20 Beijing Daxiang Biotech
11.20.1 Beijing Daxiang Biotech Company Details
11.20.2 Beijing Daxiang Biotech Business Overview
11.20.3 Beijing Daxiang Biotech Organ On Chip Introduction
11.20.4 Beijing Daxiang Biotech Revenue in Organ On Chip Business (2021–2026)
11.20.5 Beijing Daxiang Biotech Recent Development
11.21 AVATARGET
11.21.1 AVATARGET Company Details
11.21.2 AVATARGET Business Overview
11.21.3 AVATARGET Organ On Chip Introduction
11.21.4 AVATARGET Revenue in Organ On Chip Business (2021–2026)
11.21.5 AVATARGET Recent Development
11.22 Suzhou Jiyan Biopharmaceutical
11.22.1 Suzhou Jiyan Biopharmaceutical Company Details
11.22.2 Suzhou Jiyan Biopharmaceutical Business Overview
11.22.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Introduction
11.22.4 Suzhou Jiyan Biopharmaceutical Revenue in Organ On Chip Business (2021–2026)
11.22.5 Suzhou Jiyan Biopharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Organ On Chip Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Brain-on-a-chip
Table 3. Key Players of Liver-on-a-chip
Table 4. Key Players of Kidney-on-a-chip
Table 5. Key Players of Lung-on-a-chip
Table 6. Key Players of Heart-on-a-chip
Table 7. Key Players of Intestine-on-a-chip
Table 8. Key Players of Vessel-on-a-chip
Table 9. Global Organ On Chip Market Size Growth Rate by System Integration (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Single-organ-on-Chip
Table 11. Key Players of Multi-organ-on-Chip
Table 12. Global Organ On Chip Market Size Growth Rate by Chip Structure (US$ Million): 2021 vs 2025 vs 2032
Table 13. Key Players of Membrane-based Organ-on-Chip
Table 14. Key Players of Membrane-free Organ-on-Chip
Table 15. Global Organ On Chip Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Organ On Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Organ On Chip Market Size by Region (US$ Million), 2021–2026
Table 18. Global Organ On Chip Market Share by Region (2021–2026)
Table 19. Global Organ On Chip Forecasted Market Size by Region (US$ Million), 2027–2032
Table 20. Global Organ On Chip Market Share by Region (2027–2032)
Table 21. Organ On Chip Market Trends
Table 22. Organ On Chip Market Drivers
Table 23. Organ On Chip Market Challenges
Table 24. Organ On Chip Market Restraints
Table 25. Global Organ On Chip Revenue by Players (US$ Million), 2021–2026
Table 26. Global Organ On Chip Market Share by Players (2021–2026)
Table 27. Global Top Organ On Chip Players by Tier (Tier 1, Tier 2, and Tier 3), based on Organ On Chip Revenue, 2025
Table 28. Ranking of Global Top Organ On Chip Companies by Revenue (US$ Million) in 2025
Table 29. Global 5 Largest Players Market Share by Organ On Chip Revenue (CR5 and HHI), 2021–2026
Table 30. Global Key Players of Organ On Chip, Headquarters and Area Served
Table 31. Global Key Players of Organ On Chip, Products and Applications
Table 32. Global Key Players of Organ On Chip, Date of General Availability (GA)
Table 33. Mergers and Acquisitions, Expansion Plans
Table 34. Global Organ On Chip Market Size by Type (US$ Million), 2021–2026
Table 35. Global Organ On Chip Revenue Market Share by Type (2021–2026)
Table 36. Global Organ On Chip Forecasted Market Size by Type (US$ Million), 2027–2032
Table 37. Global Organ On Chip Revenue Market Share by Type (2027–2032)
Table 38. Global Organ On Chip Market Size by End User (US$ Million), 2021–2026
Table 39. Global Organ On Chip Revenue Market Share by End User (2021–2026)
Table 40. Global Organ On Chip Forecasted Market Size by End User (US$ Million), 2027–2032
Table 41. Global Organ On Chip Revenue Market Share by End User (2027–2032)
Table 42. North America Organ On Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. North America Organ On Chip Market Size by Country (US$ Million), 2021–2026
Table 44. North America Organ On Chip Market Size by Country (US$ Million), 2027–2032
Table 45. Europe Organ On Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Europe Organ On Chip Market Size by Country (US$ Million), 2021–2026
Table 47. Europe Organ On Chip Market Size by Country (US$ Million), 2027–2032
Table 48. Asia-Pacific Organ On Chip Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 49. Asia-Pacific Organ On Chip Market Size by Region (US$ Million), 2021–2026
Table 50. Asia-Pacific Organ On Chip Market Size by Region (US$ Million), 2027–2032
Table 51. Latin America Organ On Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Latin America Organ On Chip Market Size by Country (US$ Million), 2021–2026
Table 53. Latin America Organ On Chip Market Size by Country (US$ Million), 2027–2032
Table 54. Middle East & Africa Organ On Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Middle East & Africa Organ On Chip Market Size by Country (US$ Million), 2021–2026
Table 56. Middle East & Africa Organ On Chip Market Size by Country (US$ Million), 2027–2032
Table 57. Emulate Company Details
Table 58. Emulate Business Overview
Table 59. Emulate Organ On Chip Product
Table 60. Emulate Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 61. Emulate Recent Development
Table 62. MIMETAS Company Details
Table 63. MIMETAS Business Overview
Table 64. MIMETAS Organ On Chip Product
Table 65. MIMETAS Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 66. MIMETAS Recent Development
Table 67. TissUse Company Details
Table 68. TissUse Business Overview
Table 69. TissUse Organ On Chip Product
Table 70. TissUse Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 71. TissUse Recent Development
Table 72. CN Bio Innovations Company Details
Table 73. CN Bio Innovations Business Overview
Table 74. CN Bio Innovations Organ On Chip Product
Table 75. CN Bio Innovations Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 76. CN Bio Innovations Recent Development
Table 77. AIM Biotech Company Details
Table 78. AIM Biotech Business Overview
Table 79. AIM Biotech Organ On Chip Product
Table 80. AIM Biotech Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 81. AIM Biotech Recent Development
Table 82. AlveoliX Company Details
Table 83. AlveoliX Business Overview
Table 84. AlveoliX Organ On Chip Product
Table 85. AlveoliX Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 86. AlveoliX Recent Development
Table 87. Beonchip Company Details
Table 88. Beonchip Business Overview
Table 89. Beonchip Organ On Chip Product
Table 90. Beonchip Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 91. Beonchip Recent Development
Table 92. React4life Company Details
Table 93. React4life Business Overview
Table 94. React4life Organ On Chip Product
Table 95. React4life Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 96. React4life Recent Development
Table 97. InSphero Company Details
Table 98. InSphero Business Overview
Table 99. InSphero Organ On Chip Product
Table 100. InSphero Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 101. InSphero Recent Development
Table 102. NETRI Company Details
Table 103. NETRI Business Overview
Table 104. NETRI Organ On Chip Product
Table 105. NETRI Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 106. NETRI Recent Development
Table 107. SynVivo Company Details
Table 108. SynVivo Business Overview
Table 109. SynVivo Organ On Chip Product
Table 110. SynVivo Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 111. SynVivo Recent Development
Table 112. BiomimX Company Details
Table 113. BiomimX Business Overview
Table 114. BiomimX Organ On Chip Product
Table 115. BiomimX Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 116. BiomimX Recent Development
Table 117. Dynamic42 Company Details
Table 118. Dynamic42 Business Overview
Table 119. Dynamic42 Organ On Chip Product
Table 120. Dynamic42 Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 121. Dynamic42 Recent Development
Table 122. Kirkstall Company Details
Table 123. Kirkstall Business Overview
Table 124. Kirkstall Organ On Chip Product
Table 125. Kirkstall Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 126. Kirkstall Recent Development
Table 127. Cherry Biotech Company Details
Table 128. Cherry Biotech Business Overview
Table 129. Cherry Biotech Organ On Chip Product
Table 130. Cherry Biotech Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 131. Cherry Biotech Recent Development
Table 132. Micronit Company Details
Table 133. Micronit Business Overview
Table 134. Micronit Organ On Chip Product
Table 135. Micronit Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 136. Micronit Recent Development
Table 137. Cellbox Labs Company Details
Table 138. Cellbox Labs Business Overview
Table 139. Cellbox Labs Organ On Chip Product
Table 140. Cellbox Labs Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 141. Cellbox Labs Recent Development
Table 142. REVIVO BioSystems Company Details
Table 143. REVIVO BioSystems Business Overview
Table 144. REVIVO BioSystems Organ On Chip Product
Table 145. REVIVO BioSystems Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 146. REVIVO BioSystems Recent Development
Table 147. MesoBioTech Company Details
Table 148. MesoBioTech Business Overview
Table 149. MesoBioTech Organ On Chip Product
Table 150. MesoBioTech Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 151. MesoBioTech Recent Development
Table 152. Beijing Daxiang Biotech Company Details
Table 153. Beijing Daxiang Biotech Business Overview
Table 154. Beijing Daxiang Biotech Organ On Chip Product
Table 155. Beijing Daxiang Biotech Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 156. Beijing Daxiang Biotech Recent Development
Table 157. AVATARGET Company Details
Table 158. AVATARGET Business Overview
Table 159. AVATARGET Organ On Chip Product
Table 160. AVATARGET Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 161. AVATARGET Recent Development
Table 162. Suzhou Jiyan Biopharmaceutical Company Details
Table 163. Suzhou Jiyan Biopharmaceutical Business Overview
Table 164. Suzhou Jiyan Biopharmaceutical Organ On Chip Product
Table 165. Suzhou Jiyan Biopharmaceutical Revenue in Organ On Chip Business (US$ Million), 2021–2026
Table 166. Suzhou Jiyan Biopharmaceutical Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
Table 170. Authors List of This Report
List of Figures
Figure 1. Organ On Chip Picture
Figure 2. Global Organ On Chip Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Organ On Chip Market Share by Type: 2025 vs 2032
Figure 4. Brain-on-a-chip Features
Figure 5. Liver-on-a-chip Features
Figure 6. Kidney-on-a-chip Features
Figure 7. Lung-on-a-chip Features
Figure 8. Heart-on-a-chip Features
Figure 9. Intestine-on-a-chip Features
Figure 10. Vessel-on-a-chip Features
Figure 11. Other Organs Features
Figure 12. Global Organ On Chip Market Size Comparison by System Integration (US$ Million), 2021–2032
Figure 13. Single-organ-on-Chip Features
Figure 14. Multi-organ-on-Chip Features
Figure 15. Global Organ On Chip Market Size Comparison by Chip Structure (US$ Million), 2021–2032
Figure 16. Membrane-based Organ-on-Chip Features
Figure 17. Membrane-free Organ-on-Chip Features
Figure 18. Global Organ On Chip Market Size by End User (US$ Million), 2021–2032
Figure 19. Global Organ On Chip Market Share by End User: 2025 vs 2032
Figure 20. Pharmaceutical & Biotechnology Companies Case Studies
Figure 21. Academic & Research Institutes Case Studies
Figure 22. Cosmetics Industry Case Studies
Figure 23. Others Case Studies
Figure 24. Organ On Chip Report Years Considered
Figure 25. Global Organ On Chip Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 26. Global Organ On Chip Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Organ On Chip Market Share by Region: 2025 vs 2032
Figure 28. Global Organ On Chip Market Share by Players in 2025
Figure 29. Global Organ On Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Organ On Chip Revenue in 2025
Figure 31. North America Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. North America Organ On Chip Market Share by Country (2021–2032)
Figure 33. United States Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Canada Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Europe Organ On Chip Market Share by Country (2021–2032)
Figure 37. Germany Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. France Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. U.K. Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Italy Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Russia Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Ireland Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Asia-Pacific Organ On Chip Market Share by Region (2021–2032)
Figure 45. China Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Japan Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. South Korea Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Southeast Asia Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. India Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Australia & New Zealand Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Latin America Organ On Chip Market Share by Country (2021–2032)
Figure 53. Mexico Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Brazil Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Middle East & Africa Organ On Chip Market Share by Country (2021–2032)
Figure 57. Israel Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Saudi Arabia Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. UAE Organ On Chip Market Size YoY Growth (US$ Million), 2021–2032
Figure 60. Emulate Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 61. MIMETAS Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 62. TissUse Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 63. CN Bio Innovations Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 64. AIM Biotech Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 65. AlveoliX Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 66. Beonchip Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 67. React4life Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 68. InSphero Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 69. NETRI Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 70. SynVivo Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 71. BiomimX Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 72. Dynamic42 Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 73. Kirkstall Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 74. Cherry Biotech Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 75. Micronit Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 76. Cellbox Labs Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 77. REVIVO BioSystems Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 78. MesoBioTech Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 79. Beijing Daxiang Biotech Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 80. AVATARGET Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 81. Suzhou Jiyan Biopharmaceutical Revenue Growth Rate in Organ On Chip Business (2021–2026)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Organ On Chip in 2032?
The global market size of Organ On Chip in 2032 was 1368 Million USD.
Which companies rank high in the global Organ On Chip market?
What is the annual compound growth rate of the global Organ On Chip market size from 2026 to 2032?
What was the global market size of Organ On Chip in 2026?
Which region is expected to have the highest market share?
Related Reports
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 174
USD 4900.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 141
USD 4250.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 147
USD 3950.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 152
USD 3950.00
(Single User License)
Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 115
USD 4250.00
(Single User License)
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-08
Pages: 172
USD 4900.00
(Single User License)
Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published Date: 2025-09-08
Pages: 107
USD 2900.00
(Single User License)
Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 127
USD 3950.00
(Single User License)
Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)
Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Organ On Chip market is projected to grow from US$ 221 million in 2025 to US$ 1368 million by 2032, at a CAGR of 30.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 174
USD 4900.00 (Single User License)Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Organ On Chip market size was US$ 221 million in 2025 and is forecast to reach a readjusted size of US$ 1368 million by 2032 with a CAGR of 30.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 141
USD 4250.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Organ On Chip was estimated to be worth US$ 221 million in 2025 and is projected to reach US$ 1368 million, growing at a CAGR of 30.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 147
USD 3950.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 152
USD 3950.00 (Single User License)Global Organ On Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Organ On Chip market size was US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 115
USD 4250.00 (Single User License)Global Organ On Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Organ On Chip market is projected to grow from US$ 166 million in 2024 to US$ 1076 million by 2031, at a CAGR of 30.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-08
Pages: 172
USD 4900.00 (Single User License)Global Organ On Chip Market Research Report 2025
The global market for Organ On Chip was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 1076 million by 2031, growing at a CAGR of 30.2% during the forecast period.
Published: 2025-09-08
Pages: 107
USD 2900.00 (Single User License)Global Organ On Chip Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Organ On Chip was estimated to be worth US$ 156 million and is forecast to reach approximately US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Organ On Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Organ On Chip was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 31.2% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 127
USD 3950.00 (Single User License)Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now